A new class-action lawsuit alleges CVS Caremark unlawfully changed its coverage for popular GLP-1 drug Zepbound. | A new ...

A new era of weight-loss treatment could soon trade needles for pills. Drugmakers behind GLP-1 injections like Wegovy and ...

The kids are alright — on GLP-1s, that is. The data could help pave the way for younger patients to access the shots, as drugmaker Eli Lilly seeks to expand its approval beyond adults. And the stakes ...

Lots of research suggests such medications must be used indefinitely to maintain weight loss and related health benefits. But ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Weight loss can be a challenge, even for those who eat ...

People with psoriasis might receive unexpected benefits from cutting-edge weight loss drugs like Ozempic and Zepbound, German researchers said in a new study.

Elevance Health Inc. was hit with a proposed class action by a woman who says the insurer wrongly refuses to cover the weight-loss drug Zepbound for patients who need it to treat obstructive sleep ...

A class-action lawsuit accuses CVS Caremark of denying medically necessary treatments by stopping coverage of Zepbound, Eli Lilly’s blockbuster weight-loss drug.

A study found GLP-1 drugs such as Zepbound and Wegovy may offer benefits for people living with psoriasis, HealthDay reported Sept. 18.  In the ...

What used to be a whisper— I’m on Ozempic —has recently become a shout. Celebrities like Serena Williams, Oprah, and Kelly ...

Wegovy has been a hugely popular treatment since the Food and Drug Administration (FDA) approved it for weight loss in ...

Medicare and Medicaid coverage of GLP-1 weight loss drugs could be just what the doctor ordered for these two struggling ...